| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032732 |
| Receipt No. | R000037332 |
| Official scientific title of the study | Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancer |
| Date of disclosure of the study information | 2018/08/01 |
| Last modified on | 2018/05/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancer | |
| Title of the study (Brief title) | Chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancer | |
| Region |
|
|
| Condition | ||
| Condition | locally advenced tongue cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and toxicity of alternating chemoradiotherapy followed by proton beam therapy combined with intra-arterial infusion chemotherapy for locally advanced tongue cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | overall survival rate |
| Key secondary outcomes | local control rate, locoregional control rate, progression free survival rate, toxicity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Treatment consisted of 2 courses of alternating chemoradiotherapy (radiotherapy:4 weeks) and intra-arterial infusion chemotherapy(cisplatin 20-40mg/m2) combined with 3 weeks of proton beam therapy
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Untreated tongue cancer
2)Histologically confirmed squamous cell carcinoma 3)Stage III-IV(UICC ver.7) 4)Performance status:0-2(ECOG) 5)18-70 years old 6)WBC:>3,000/mm2, Platelet count:>100,000/mm2, Hemoglobin:>9g/dl 7)No history of radiotherapy or surgery for the head and neck region |
|||
| Key exclusion criteria | 1)History of serious drug allegies
2)With severe complications(hepatic disorder, renal disorder, heart disorder, cerebral infraction) |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kanako Takayama |
| Organization | Southern Tohoku Proton Therapy Center |
| Division name | department of radiation oncology |
| Address | 7-172, Yatsuyamada, Koriyama, Fukushima |
| TEL | 024-934-3888 |
| tkana-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Kanako Takayama |
| Organization | Southern Tohoku Proton Therapy Center |
| Division name | department of radiation oncology |
| Address | 7-172, Yatsuyamada, Koriyama, Fukushima |
| TEL | 024-934-3888 |
| Homepage URL | |
| tkana-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Department of radiation oncology, Southern Tohoku Proton Therapy Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Southern Tohoku General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://link.springer.com/article/10.1007/s00432-015-2069-0 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037332 |